Glaxosmithkline | GSK - 销售成本

金融业

GBP

GBP 62.87B

现金及等价物

GBP 3.44B

GBP 1.88B

GBP 17.76B

GBP 22.43B

GBP 19.06B

股息收益率

GBP 4.47

GBP 2.31B

GBP 2.77B

GBP 69.4K

EPS每股收益

GBP 0.62

股本和储备

GBP 17.42B

GBP 5.75B

债务利息支出

GBP 192.73M

GBP 22M

GBP 18.53B

GBP 106.21B

GBP 1.74B

GBP 5.34B

GBP 2.29B

普通股股本

GBP 4.05B

15.09

GBP 2.14B

GBP 10.09B

销售和管理费用

GBP 2.12B

GBP 6.16B

贸易债权人

GBP 14.34B

应收帐款人

GBP 10.49B

	销售成本	更改		日
AbbVie	USD 4.22B		329M	2026-03
Amgen	USD 1.6B		187M	2026-03
AstraZeneca	USD -204M		3.48B	2026-03
Aurora Cannabis	CAD 8.22M		80.38M	2026-03
Bausch Health Companies	USD 979M		55M	2026-03
Bristol-Myers Squibb	USD 3.86B		1.07B	2026-03
Canopy Growth	CAD 62.98M		9.91M	2026-03
Corcept Therapeutics	USD 2.88M		338K	2026-03
Drreddys Laboratories	INR 32.13B		8.34B	2026-03
Eli Lilly	USD 3.58B		205M	2026-03
GlaxoSmithKline	GBP 1.88B		736M	2026-03
Glaxosmithkline	GBP 1.88B		1.6B	2026-03
J&J	USD 8B		67M	2026-06
Merck	USD 2.94B		380M	2026-03
Novartis	USD 3.46B		83M	2026-03
Pacira	USD 50.74M		3.89M	2026-03
Perrigo	USD 643.7M		103.7M	2026-03
Pfizer	USD 4.59B		1.7B	2026-03
Phibro Animal Health	USD 240.42M		2.58M	2025-12
Prestige Brands	USD 140.76M		9.53M	2026-03
Roche Holding	CHF 8.48B		4.61B	2025-12
Sanofi	EUR 3.67B		621M	2026-03
Supernus Pharmaceuticals	USD 49.04M		1.5M	2026-03
Takeda	JPY 560.54B		159.39B	2026-03
Teva Pharmaceutical Industries	USD 2.01B		46M	2026-03
Zoetis	USD 672M		71M	2026-03